Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Contineum Therapeutics, Inc. CTNM

Set alert

Price alert · CTNM

All alert types
9.39 USD 0.00 0.00%

At close

9.28 -0.11 -1.17%

Pre-market · Nov 2, 8:49 AM ET

Bid
9.37 × 1
Ask
9.39 × 1
8.94 Day range 9.58
6.73 52-week range 17.79
YTD
-17.85%
1 year
-10.91%
Open
9.14
Prev close
9.39
Mkt cap
353.26M
Vol
294.54K
Avg vol
834.36K
EPS
-1.73
P/E
0.00
Div yield
0.00%
More statistics
Low
8.94
High
9.58
Forward P/E
-7.68
Beta
0.00
Short ratio
13.66
Inst. own
72.39%
Dividend
0.00
Ex-div date
Earnings
Feb 5, 2025
50-d avg
15.77
200-d avg
17.15
1y target
29.25

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for CTNM has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

16.44 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 3

Valuation

P/E -5.3×
FY 2021: -13.4×FY 2022: -15.9×FY 2023: 118×FY 2024: -9.0×FY 2025: -5.3×
FY 2021 5y median -9.0× FY 2025
P/S 0.0×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 7.7×FY 2024: 0.0×FY 2025: 0.0×
FY 2021 5y median 0.0× FY 2025
P/B 1.2×
FY 2021: 6.3×FY 2022: 9.9×FY 2023: -5.7×FY 2024: 1.9×FY 2025: 1.2×
FY 2021 5y median 1.9× FY 2025
P/FCF -5.7×
FY 2021: -14.6×FY 2022: -19.1×FY 2023: 20.4×FY 2024: -11.4×FY 2025: -5.7×
FY 2021 5y median -11.4× FY 2025
EV/EBITDA -3.7×
FY 2021: -13.7×FY 2022: -16.5×FY 2023: 24.0×FY 2024: -8.6×FY 2025: -3.7×
FY 2021 5y median -8.6× FY 2025
EV/Sales 0.0×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 11.3×FY 2024: 0.0×FY 2025: 0.0×
FY 2021 5y median 0.0× FY 2025
FCF Yield -17.5%
FY 2021: -6.8%FY 2022: -5.2%FY 2023: 4.9%FY 2024: -8.8%FY 2025: -17.5%
FY 2021 5y median -6.8% FY 2025

Profitability

Gross Margin 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 100.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: -32.2%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 45.4%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
ROE -23.0%
FY 2021: -47.1%FY 2022: -61.8%FY 2023: -33.4%FY 2024: -21.3%FY 2025: -23.0%
FY 2021 5y median -33.4% FY 2025
ROIC -25.3%
FY 2021: -42.1%FY 2022: -47.2%FY 2023: -12.6%FY 2024: -24.9%FY 2025: -25.3%
FY 2021 5y median -25.3% FY 2025
ROA -21.7%
FY 2021: -41.1%FY 2022: -47.9%FY 2023: 17.4%FY 2024: -19.9%FY 2025: -21.7%
FY 2021 5y median -21.7% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -100.0%FY 2025: 0.0%
FY 2021 FY 2025
Operating Income -33.7%
FY 2021: 0.0%FY 2022: 20.7%FY 2023: 29.2%FY 2024: -216.6%FY 2025: -33.7%
FY 2021 FY 2025
EPS (diluted) -33.1%
FY 2021: 0.0%FY 2022: 15.7%FY 2023: 113.4%FY 2024: -1353.8%FY 2025: -33.1%
FY 2021 FY 2025
Free Cash Flow -66.5%
FY 2021: 0.0%FY 2022: 23.4%FY 2023: 193.6%FY 2024: -276.2%FY 2025: -66.5%
FY 2021 FY 2025

Financial Health

Current Ratio 27.5×
FY 2021: 19.0×FY 2022: 6.4×FY 2023: 23.3×FY 2024: 20.7×FY 2025: 27.5×
FY 2021 5y median 20.7× FY 2025
Quick Ratio 27.5×
FY 2021: 19.0×FY 2022: 6.4×FY 2023: 23.3×FY 2024: 20.7×FY 2025: 27.5×
FY 2021 5y median 20.7× FY 2025
Debt / Equity 0.0×
FY 2021: 0.1×FY 2022: 0.1×FY 2023: -2.8×FY 2024: 0.0×FY 2025: 0.0×
FY 2021 5y median 0.0× FY 2025
Net Debt / EBITDA 1.0×
FY 2021: -0.0×FY 2022: -0.0×FY 2023: 7.5×FY 2024: 0.4×FY 2025: 1.0×
FY 2021 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2021: -86.3×FY 2022: -58.6×FY 2023: -77.3×FY 2024: 0.0×FY 2025: 0.0×
FY 2021 5y median -58.6× FY 2025

Dividends

Dividend Yield 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31